Development And Epilepsy - Strategies For Innovative Research To Improve Diagnosis, Prevention And Treatment In Children With Difficult To Treat Epilepsy
Funder
National Health and Medical Research Council
Funding Amount
$456,083.00
Summary
By deciphering pathophysiological mechanisms in epileptogenic developmental disorders and developing mechanism-related, and advanced therapeutic strategies, we expect to discover novel genes and related molecular pathways that are involved in epilepsy and similar disorders. DESIRE will also help preventing the development of the disease after potentially epileptogenic brain insults.
From Brain Maps To Mechanisms: Modelling The Pathophysiology Of Dementia
Funder
National Health and Medical Research Council
Funding Amount
$604,513.00
Summary
As the brain ages, the relationship between its structure and function also changes. In this study, I will use detailed computational modelling and extensive analyses of brain dynamics to improve interventional strategies by: 1. Characterising healthy and unhealthy brain dynamics during ageing; 2. Classifying the various subtypes of pathological dynamics; and 3. Predicting pathological neurodegeneration by identifying the earliest signs of perturbations in healthy ageing.
The Effect Of Chronic Intermittent Alcohol Consumption On The Precipitation Of Dementia.
Funder
National Health and Medical Research Council
Funding Amount
$604,644.00
Summary
This proposal examines the relationship between chronic alcohol intake and alcohol-related dementia, and potential interventions for the treatment of alcohol related dementia.
Vascular Cognitive Risk Score: Quantifying The Vascular Burden In Alzheimer's Disease
Funder
National Health and Medical Research Council
Funding Amount
$627,180.00
Summary
What causes dementia in a patient presenting to a clinic is often uncertain. While there are exciting potential treatments in the pipeline, we need to understand the cause of the disease in a specific patient to make correct treatment decisions. Stroke and other vascular diseases of the brain cause a significant proportion of dementia in the community. Using MRI scanning technology, this project will quantify this burden in a given patient by developing a ‘vascular cognitive risk' (VCR) score.
A Telehealth Intervention To Delay Functional Decline In Community-dwelling People With Dementia
Funder
National Health and Medical Research Council
Funding Amount
$476,399.00
Summary
Telehealth programs are becoming increasingly popular as a way to increase the accessibility of services and reduce the costs associated with health professionals travelling to the client's home. This project will examine whether an evidence based intervention that delays functional decline can be delivered via videoconferencing and whether this method of delivery is as effective.
Novel Targeted Degradable Multifunctional Poly(vinyl-co-ester) Nanoparticles For Alzheimer’s Disease Applications
Funder
National Health and Medical Research Council
Funding Amount
$601,940.00
Summary
Novel biodegradable polymeric nanoparticles for efficient and targeted delivery of Alzheimer related agents to the brain will be developed. The nanocarriers will be fabricated from biocompatible multifunctional compounds and possess the capability to co-deliver diagnostic and therapeutic agents across the blood-brain barrier. These systems are expected to become a new efficient class of brain delivery systems.
Dementia Associated To Diabetes: Prevention Through The Modulation Of Cerebrovascular Integrity
Funder
National Health and Medical Research Council
Funding Amount
$719,770.00
Summary
Diabetic insulin resistance is reported to induce cognitive decline and dementia. An accumulating body of evidence suggest that compromised integrity of neurovascular unit and following changes in cerebral lipid homeostasis may be centrally involved in the neurodegeneration and cognitive deficits. Therefore, the project aims to prevent the insulin resistance-associated cognitive impairment by modulating the integrity of cerebrovasculature and lipid homeostasis.
Understanding And Preventing Physical And Cognitive Decline And Falls In Older People With Dementia
Funder
National Health and Medical Research Council
Funding Amount
$509,626.00
Summary
Falls are common in people with dementia and are more likely to result in injury, death and institutionalisation. There is limited evidence that falls can be prevented in this group. Strategies aimed at maintaining independence and preventing decline and falls are urgently needed. This research will a) further our understanding of fall risk and functional decline and b) explore novel fall and decline prevention programs, including the use of technology in older people with dementia.
Optimising Functional Independence Of Older Persons With Dementia: Implementation And Evaluation Of The Interdisciplinary Home-bAsed Reablement Program (I-HARP)
Funder
National Health and Medical Research Council
Funding Amount
$1,864,345.00
Summary
We propose to trial a practical, evidence based model, called the Interdisciplinary Home-bAsed Reablement Program, I-HARP, designed to improve functional independence of community dwelling older people with dementia. I-HARP will be implemented and evaluated, for its effectiveness and implementation outcomes in two different settings of hospital and community aged care. Ultimately, the program will help them live well and stay at home, while delaying entry into higher home or residential care.
Combined TMS-EEG For Early Diagnosis Of Alzheimer’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$603,767.00
Summary
Early diagnosis of Alzheimer's disease is key to more effective early intervention. Current biomarkers are expensive and are not suited for detecting the subtle changes in brain function that occur during the initial stages of the disease. Non-invasive brain stimulation is pain-free and inexpensive, and can directly probe brain function in conscious humans. This project will investigate whether these techniques might be used to identify markers of early brain dysfunction in Alzheimer’s disease.